Teradyne, Backlogs, and Barriers to EntryIt's hard to enter the market during a capacity crisisDoug O'LaughlinDec 02, 2021∙ Paid64ShareThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext